DR. Shahram Bonyadlou, M.D. is a nuclear medicine in Los Angeles, CA with 25 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone DR. Shahram Bonyadlou, M.D. NPI is 1982651915. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1500 SAN PABLO ST FL 2
LOS ANGELES, CA
ZIP 90033-313
Phone: (323) 442-8541
The NPI 1982651915 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Nuclear medicine study with ct imaging skull base to mid-thigh (HCPCS:78815)
- Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
- Bone density measurement using dedicated x-ray machine (HCPCS:77080)
- X-ray of chest, 2 views (HCPCS:71046)
- Automated urinalysis test (HCPCS:81003)
- Nuclear medicine study of vessels of heart using drugs or exercise multiple studies (HCPCS:78452)
- Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report (HCPCS:93010)
- Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers (HCPCS:93970)
- Bone and/or joint imaging, whole body (HCPCS:78306)
- X-ray of knee, 3 views (HCPCS:73562)
- Ultrasound study of arteries and arterial grafts of both legs (HCPCS:93925)
- Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck (HCPCS:93880)
- Nuclear medicine study with ct imaging whole body (HCPCS:78816)
- Ct scan chest (HCPCS:71250)
The enumeration date for this NPI number is 5/27/2006 and was last updated on 11/27/2023.